骨转移的前列腺癌患者的临床试验
总计1433个结果
-
Alliance Foundation Trials, LLC.Bayer招聘中
-
Dana-Farber Cancer InstituteNovartis尚未招聘
-
University of California, San FranciscoConquer Cancer Foundation完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
Roswell Park Cancer Institute撤销去势抵抗性前列腺癌 | IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | PSA 进展 | 软组织转移性前列腺癌 | 睾酮的去势水平 | 前列腺癌骨转移 | PSA 水平大于或等于 2美国
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAstraZeneca招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Clarus Therapeutics招聘中
-
Jeanne LinkOregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center of Radiochemistry...批准上市
-
Vadim S KoshkinEli Lilly and Company; Prostate Cancer Foundation主动,不招人去势抵抗性前列腺癌 | IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8 | 转移性去势抵抗性前列腺癌 | 转移性前列腺癌 | 转移性去势抵抗性前列腺癌美国
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Epizyme, Inc.; Pfizer主动,不招人
-
Epizyme, Inc.主动,不招人
-
AstraZeneca完全的具有腺癌和非腺癌组织学的 aNSCLC 患者(局部晚期和/或转移性疾病)的 EGFR 突变状态。意大利, 西班牙, 英国, 瑞典, 日本, 荷兰, 德国, 法国
-
Northwestern UniversityNational Cancer Institute (NCI); AstraZeneca主动,不招人转移性前列腺癌 | IV 期前列腺癌 | 前列腺癌转移性去势抵抗 | 异常DNA修复美国
-
Liaoning Tumor Hospital & Institute尚未招聘Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer
-
Erasmus Medical CenterSanofi主动,不招人
-
Sun Yat-sen University尚未招聘
-
Massachusetts General HospitalPfizer; Prostate Cancer Foundation; Calithera Biosciences, Inc尚未招聘
-
Radboud University Medical CenterVGZ health insurance (NL); Paul Speth Foundation (NL); Radboud Oncology Fund (NL)招聘中
-
Association Pour La Recherche des Thérapeutiques...完全的
-
Eli Lilly and CompanySarah Cannon Development Innovations完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...完全的
-
Sanofi完全的
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer Institute终止
-
Accelerated Community Oncology Research NetworkBayer终止